Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C24H21ClN2O3 |
| Molecular Weight | 420.888 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O[C@H]1CCN(C1)C(=O)C2=C3N(CCC4=CC=C(Cl)C=C34)C(=O)C(=C2)C5=CC=CC=C5
InChI
InChIKey=ASOBQUGZPVVXJT-SFHVURJKSA-N
InChI=1S/C24H21ClN2O3/c25-17-7-6-16-8-11-27-22(19(16)12-17)21(23(29)26-10-9-18(28)14-26)13-20(24(27)30)15-4-2-1-3-5-15/h1-7,12-13,18,28H,8-11,14H2/t18-/m0/s1
| Molecular Formula | C24H21ClN2O3 |
| Molecular Weight | 420.888 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:15:36 GMT 2025
by
admin
on
Mon Mar 31 21:15:36 GMT 2025
|
| Record UNII |
EIR1Q66583
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
LIREQUINIL
Created by
admin on Mon Mar 31 21:15:36 GMT 2025 , Edited by admin on Mon Mar 31 21:15:36 GMT 2025
|
PRIMARY | |||
|
143943-72-0
Created by
admin on Mon Mar 31 21:15:36 GMT 2025 , Edited by admin on Mon Mar 31 21:15:36 GMT 2025
|
PRIMARY | |||
|
EIR1Q66583
Created by
admin on Mon Mar 31 21:15:36 GMT 2025 , Edited by admin on Mon Mar 31 21:15:36 GMT 2025
|
PRIMARY | |||
|
14770131
Created by
admin on Mon Mar 31 21:15:36 GMT 2025 , Edited by admin on Mon Mar 31 21:15:36 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Ro 41-3290 induced moderate, dose-independent effects, which were most pronounced at 4 h after intake. Long-term memory, as assessed by a word learning and recall test, was not clearly affected by any drug. The pharmacokinetics of Ro 41-3290 were dose proportional with an elimination half-life of approximately 8 h. The relatively slow absorption of Ro 41-3290 (t(max) approximately 2.5 h) and the concentration-effect time delay do not make it a good candidate to replace its parent compound Ro 41-3696 as an investigational hypnotic.
|